The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Underlying the Mechanisms of Doxorubicin-Induced Acute Cardiotoxicity: Oxidative Stress and Cell Death
Open accessAbstract
Cancer is a destructive disease that causes high levels of morbidity and mortality. Doxorubicin (DOX) is a highly efficient antineoplastic chemotherapeutic drug, but its use places survivors at risk for cardiotoxicity. Many studies have demonstrated that multiple factors are involved in DOX-induced acute cardiotoxicity. Among them, oxidative stress and cell death predominate. In this review, we provide a comprehensive overview of the mechanisms underlying the source and effect of free radicals and dependent cell death pathways induced by DOX. Hence, we attempt to explain the cellular mechanisms of oxidative stress and cell death that elicit acute cardiotoxicity and provide new insights for researchers to discover potential therapeutic strategies to prevent or reverse doxorubicin-induced cardiotoxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reactive oxygen species and antioxidant machinery in abiotic stress tolerance in crop plants
Gill, S. S., & Tuteja, N. (2010) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2010.08.016 · Cited by 11,663
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
Role of nrf2 in oxidative stress and toxicity
Ma, Q. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140320 · Cited by 4,903
Global Cancer Incidence and Mortality Rates and Trends—An Update
Torre, L. A., Siegel, R. L., Ward, E. M., & Jemal, A. (2016) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0578 · Cited by 3,692
Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
VON HOFF, D. D., LAYARD, M. W., BASA, P., DAVIS, H. L., VON HOFF, A. L., ROZENCWEIG, M., & MUGGIA, F. M. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-5-710 · Cited by 2,391
Ferroptosis as a target for protection against cardiomyopathy
Fang, X., Wang, H., Han, D., Xie, E., Yang, X., Wei, J., Gu, S., Gao, F., Zhu, N., Yin, X., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821022116 · Cited by 2,127
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Zhang, S., Liu, X., Bawa-Khalfe, T., Lu, L.-S., Lyu, Y. L., Liu, L. F., & Yeh, E. T. H. (2012) · Nature Medicine · doi:10.1038/nm.2919 · Cited by 1,948
A clinicopathologic analysis of adriamycin cardiotoxicity
Lefrak, E. A., Piťha, J., Rosenheim, S., & Gottlieb, J. A. (1973) · Cancer · doi:10.1002/1097-0142(197308)32:2<302::aid-cncr2820320205>3.0.co;2-2 · Cited by 1,560
The Human Sir2 Ortholog, SIRT2, Is an NAD+-Dependent Tubulin Deacetylase
North, B. J., Marshall, B. L., Borra, M. T., Denu, J. M., & Verdin, E. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00038-8 · Cited by 1,536
Michishita, E., Park, J. Y., Burneskis, J. M., Barrett, J. C., & Horikawa, I. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-01-0033 · Cited by 1,364
Insight into the mechanism of ferroptosis inhibition by ferrostatin-1
Miotto, G., Rossetto, M., Di Paolo, M. L., Orian, L., Venerando, R., Roveri, A., Vučković, A.-M., Bosello Travain, V., Zaccarin, M., Zennaro, L., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2019.101328 · Cited by 906
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
Ichikawa, Y., Ghanefar, M., Bayeva, M., Wu, R., Khechaduri, A., Prasad, S. V. N., Mutharasan, R. K., Naik, T. J., & Ardehali, H. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72931 · Cited by 878
ATF3 promotes erastin-induced ferroptosis by suppressing system Xc–
Wang, L., Liu, Y., Du, T., Yang, H., Lei, L., Guo, M., Ding, H.-F., Zhang, J., Wang, H., Chen, X., et al. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0380-z · Cited by 809
Enzymatic Defenses of the Mouse Heart Against Reactive Oxygen Metabolites
Doroshow, J. H., Locker, G. Y., & Myers, C. E. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109642 · Cited by 702
Regulated cell death pathways in doxorubicin-induced cardiotoxicity
Christidi, E., & Brunham, L. R. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03614-x · Cited by 684
Nox family NADPH oxidases: Molecular mechanisms of activation
Brandes, R. P., Weissmann, N., & Schröder, K. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.07.046 · Cited by 673
Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity
Tadokoro, T., Ikeda, M., Ide, T., Deguchi, H., Ikeda, S., Okabe, K., Ishikita, A., Matsushima, S., Koumura, T., Yamada, K.-I., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.132747 · Cited by 655
Singh, A., Venkannagari, S., Oh, K. H., Zhang, Y.-Q., Rohde, J. M., Liu, L., Nimmagadda, S., Sudini, K., Brimacombe, K. R., Gajghate, S., et al. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00651 · Cited by 617
Fundamentals on the biochemistry of peroxynitrite and protein tyrosine nitration
Bartesaghi, S., & Radi, R. (2018) · Redox Biology · doi:10.1016/j.redox.2017.09.009 · Cited by 485
Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification
Li, D. L., Wang, Z. V., Ding, G., Tan, W., Luo, X., Criollo, A., Xie, M., Jiang, N., May, H., Kyrychenko, V., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.017443 · Cited by 464
Yen, H. C., Oberley, T. D., Vichitbandha, S., Ho, Y. S., & St Clair, D. K. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118909 · Cited by 459
Zhang, X., Hu, C., Kong, C.-Y., Song, P., Wu, H.-M., Xu, S.-C., Yuan, Y.-P., Deng, W., Ma, Z.-G., & Tang, Q.-Z. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0372-z · Cited by 442
Self-citationZeng, C., Duan, F., Hu, J., Luo, B., Huang, B., Lou, X., Sun, X., Li, H., Zhang, X., Yin, S., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101523 · Cited by 384
Self-citationMukhopadhyay, P., Rajesh, M., Bátkai, S., Kashiwaya, Y., Haskó, G., Liaudet, L., Szabó, C., & Pacher, P. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00795.2008 · Cited by 376
Zhao, L., Qi, Y., Xu, L., Tao, X., Han, X., Yin, L., & Peng, J. (2018) · Redox Biology · doi:10.1016/j.redox.2017.12.013 · Cited by 344
Kang, Y. J., Chen, Y., & Epstein, P. N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.21.12610 · Cited by 303
Coats, B. R., Schoenfelt, K. Q., Barbosa-Lorenzi, V. C., Peris, E., Cui, C., Hoffman, A., Zhou, G., Fernandez, S., Zhai, L., Hall, B. A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.096 · Cited by 291
Malliaras, K., Zhang, Y., Seinfeld, J., Galang, G., Tseliou, E., Cheng, K., Sun, B., Aminzadeh, M., & Marbán, E. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201737 · Cited by 290
Nox2 NADPH Oxidase Promotes Pathologic Cardiac Remodeling Associated with Doxorubicin Chemotherapy
Zhao, Y., McLaughlin, D., Robinson, E., Harvey, A. P., Hookham, M. B., Shah, A. M., McDermott, B. J., & Grieve, D. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2664 · Cited by 244
Hu, C., Zhang, X., Song, P., Yuan, Y.-P., Kong, C.-Y., Wu, H.-M., Xu, S.-C., Ma, Z.-G., & Tang, Q.-Z. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101747 · Cited by 244
Self-citationNADPH oxidase 4 is an oncoprotein localized to mitochondria
Graham, K. A., Kulawiec, M., Owens, K. M., Li, X., Desouki, M. M., Chandra, D., & Singh, K. K. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.3.12207 · Cited by 236
Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function
Lakhal-Littleton, S., Wolna, M., Carr, C. A., Miller, J. J. J., Christian, H. C., Ball, V., Santos, A., Diaz, R., Biggs, D., Stillion, R., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422373112 · Cited by 234
Gupta, S. K., Garg, A., Bär, C., Chatterjee, S., Foinquinos, A., Milting, H., Streckfuß-Bömeke, K., Fiedler, J., & Thum, T. (2018) · Circulation Research · doi:10.1161/circresaha.117.311335 · Cited by 227
The role of Bcl-2 family member BNIP3 in cell death and disease: NIPping at the heels of cell death
Burton, T. R., & Gibson, S. B. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.185 · Cited by 216
Han, D., Wang, Y., Wang, Y., Dai, X., Zhou, T., Chen, J., Tao, B., Zhang, J., & Cao, F. (2020) · Circulation Research · doi:10.1161/circresaha.119.316061 · Cited by 203
Kuzu, M., Kandemir, F. M., Yildirim, S., Kucukler, S., Caglayan, C., & Turk, E. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.161 · Cited by 195
Pacher, P., Liaudet, L., Bai, P., Virag, L., Mabley, J. G., Haskó, G., & Szabó, C. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.862 · Cited by 188
Hu, C., Zhang, X., Zhang, N., Wei, W., Li, L., Ma, Z., & Tang, Q. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.124 · Cited by 186
Self-citationSingla, D., Johnson, T., & Tavakoli Dargani, Z. (2019) · Cells · doi:10.3390/cells8101224 · Cited by 182
Cheung, K. G., Cole, L. K., Xiang, B., Chen, K., Ma, X., Myal, Y., Hatch, G. M., Tong, Q., & Dolinsky, V. W. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.607960 · Cited by 174
Kawaguchi, T., Takemura, G., Kanamori, H., Takeyama, T., Watanabe, T., Morishita, K., Ogino, A., Tsujimoto, A., Goto, K., Maruyama, R., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs282 · Cited by 172
Topal, G., Brunet, A., Millanvoye, E., Boucher, J.-L., Rendu, F., Devynck, M.-A., & David-Dufilho, M. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.03.019 · Cited by 167
Neilan, T. G., Blake, S. L., Ichinose, F., Raher, M. J., Buys, E. S., Jassal, D. S., Furutani, E., Perez-Sanz, T. M., Graveline, A., Janssens, S. P., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.652339 · Cited by 167
Dargani, Z. T., & Singla, D. K. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00056.2019 · Cited by 159
Pillai, V. B., Bindu, S., Sharp, W. W., Fang, Y. H., Kim, G. H., Gupta, M., Samant, S. A., & Gupta, M. P. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00832.2015 · Cited by 157
Milano, G., Biemmi, V., Lazzarini, E., Balbi, C., Ciullo, A., Bolis, S., Ameri, P., Silvestre, D. D., Mauri, P., Barile, L., et al. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz108 · Cited by 151
Bnip3 mediates doxorubicin-induced cardiomyocyte pyroptosis via caspase-3/GSDME
Zheng, X., Zhong, T., Ma, Y., Wan, X., Qin, A., Yao, B.-F., Zou, H., Song, Y., & Yin, D. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117186 · Cited by 151
Yuan, Y., Ma, Z., Zhang, X., Xu, S., Zeng, X., Yang, Z., Deng, W., & Tang, Q. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.10.008 · Cited by 149
Self-citationRole of acetylation in doxorubicin-induced cardiotoxicity
Li, D., Yang, Y., Wang, S., He, X., Liu, M., Bai, B., Tian, C., Sun, R., Yu, T., & Chu, X. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102089 · Cited by 147
Yen, H., Oberley, T. D., Gairola, C. G., Szweda, L. I., & Clair, D. K. S. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.1011 · Cited by 142
Human Sir2 and the ‘silencing’ of p53 activity
Smith, J. S. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(02)02342-5 · Cited by 141
Sahu, B. D., Kumar, J. M., Kuncha, M., Borkar, R. M., Srinivas, R., & Sistla, R. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.11.018 · Cited by 141
Sag, C. M., Köhler, A. C., Anderson, M. E., Backs, J., & Maier, L. S. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.07.016 · Cited by 139
Russo, M., Guida, F., Paparo, L., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1439 · Cited by 124
Liu, Y., Zeng, L., Yang, Y., Chen, C., Wang, D. W., & Wang, H. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02948-2 · Cited by 119
The protective roles of nitric oxide and superoxide dismutase in adriamycin-induced cardiotoxicity
Cole, M. P., Chaiswing, L., Oberley, T. D., Edelmann, S. E., Piascik, M. T., LIN, S., Kiningham, K. K., & Clair, D. K. S. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.07.012 · Cited by 110
Zhang, Q.-L., Yang, J.-J., & Zhang, H.-S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.037 · Cited by 110
Gp91phox-containing NAD(P)H oxidase increases superoxide formation by doxorubicin and NADPH
Deng, S., Kruger, A., Kleschyov, A. L., Kalinowski, L., Daiber, A., & Wojnowski, L. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.11.013 · Cited by 109
Sin, T. K., Tam, B. T., Yung, B. Y., Yip, S. P., Chan, L., Wong, S. C. C., Ying, M. T. C., Rudd, J. A., & Siu, P. M. (2015) · The Journal of Physiology · doi:10.1113/jphysiol.2014.270101 · Cited by 107
Mantawy, E. M., Esmat, A., El‐Bakly, W. M., Din, R. A. S. E., & El‐Demerdash, E. (2017) · Scientific Reports · doi:10.1038/s41598-017-05005-9 · Cited by 107
Contractile Function During Angiotensin-II Activation
Zhang, M., Prosser, B. L., Bamboye, M. A., Gondim, A. N. S., Santos, C. X. C., Martin, D., Ghigo, A., Perino, A., Brewer, A. C., Ward, C. W., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.05.020 · Cited by 97
Xiong, Y., Liu, X., Lee, C.-P., Chua, B. H. L., & Ho, Y.-S. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.02.024 · Cited by 96
do Nascimento, T. C., Cazarin, C. B. B., Maróstica, M. R., Mercadante, A. Z., Lopes, E. J., & Zepka, L. Q. (2019) · Food Research International · doi:10.1016/j.foodres.2019.108770 · Cited by 88
Yarana, C., Carroll, D. W., Chen, J., Chaiswing, L., Zhao, Y., Noel, T. J., Alstott, M. C., Bae, Y., Dressler, E. V. M., Moscow, J. A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2046 · Cited by 85
Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity
Tadokoro, T., Ikeda, M., Ide, T., Deguchi, H., Ikeda, S., Okabe, K., Ishikita, A., Matsushima, S., Koumura, T., Yamada, K., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.169756 · Cited by 83
Improvement of doxorubicin induced cardiomyopathy in rats treated with insulin-like growth factor I
Ambler, G. R., Johnston, B. M., Maxwell, L., et al. (1993) · Cardiovascular Research · doi:10.1093/cvr/27.7.1368 · Cited by 81
Berberine-induced cardioprotection and Sirt3 modulation in doxorubicin-treated H9c2 cardiomyoblasts
Coelho, A. R., Martins, T. R., Couto, R., Deus, C. M., Pereira, C. V., Simões, R. F., Rizvanov, A. A., Silva, F. S. G., Cunha‐Oliveira, T., Oliveira, P. J., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.030 · Cited by 80
Mai, F., He, P., Ye, J., Xu, L., Ouyang, D., Li, C., Zeng, Q., Zeng, C., Zhang, C., He, X., et al. (2019) · Cell Proliferation · doi:10.1111/cpr.12663 · Cited by 77
Nithipongvanitch, R., Ittarat, W., Cole, M. P., Tangpong, J., Clair, D. K. S., & Oberley, T. D. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1632 · Cited by 72
Marechal, X., Montaigne, D., Marciniak, C., Marchetti, P., Hassoun, S. M., Beauvillain, J. C., Lancel, S., & Nevière, R. (2011) · Clinical Science · doi:10.1042/cs20110069 · Cited by 69
Targeting OCT3 attenuates doxorubicin-induced cardiac injury
Huang, K. M., Thomas, M. Z., Magdy, T., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020168118 · Cited by 66
Yu, Y., Fan, S., Shu, L., Huang, W., Xie, L., Bi, C., Yu, H., Wang, Y., & Li, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.600561 · Cited by 65
Poly(ADP-ribose) polymerase-2 depletion reduces doxorubicin-induced damage through SIRT1 induction
Szántó, M., Rutkai, I., Hegedűs, C., Czikora, Á., Rózsahegyi, M., Kiss, B., Virág, L., Gergely, P., Tóth, A., & Bai, P. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr246 · Cited by 59
Akolkar, G., Bagchi, A. K., Ayyappan, P., Jassal, D. S., & Singal, P. K. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00356.2016 · Cited by 58
P53 enhances apoptosis induced by doxorubicin only under conditions of severe DNA damage
Lin, R., Ho, C.-J., Chen, H.-W., Pao, Y., Chen, L.-E., Yang, M.-C., Huang, S., Wang, S., Chen, C., & Wang, C. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1520565 · Cited by 58
Toll-like receptor 5 deficiency diminishes doxorubicin-induced acute cardiotoxicity in mice
Ma, Z., Kong, C., Wu, H., Song, P. K., Zhang, X., Yuan, Y., Deng, W., & Tang, Q. (2020) · Theranostics · doi:10.7150/thno.47516 · Cited by 58
Self-citationP53 inhibition exacerbates late-stage anthracycline cardiotoxicity
Zhu, W., Zhang, W., Shou, W., & Field, L. J. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu118 · Cited by 57
Ali, M., Kamjoo, M., Thomas, H. D., Kyle, S., Pavlovska, I., Babur, M., Telfer, B. A., Curtin, N. J., & Williams, K. J. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0356 · Cited by 56
Peroxisomes contribute to oxidative stress in neurons during doxorubicin-based chemotherapy
Moruno-Manchon, J. F., Uzor, N.-E., Kesler, S. R., Wefel, J. S., Townley, D. M., Nagaraja, A. S., Pradeep, S., Mangala, L. S., Sood, A. K., & Tsvetkov, A. S. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.11.014 · Cited by 55
McLaughlin, D., Zhao, Y., O’Neill, K. M., Edgar, K. S., Dunne, P. D., Kearney, A. M., Grieve, D., & McDermott, B. J. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13773 · Cited by 54
Intercalating TOP2 Poisons Attenuate Topoisomerase Action at Higher Concentrations
Atwal, M., Swan, R. L., Rowe, C., Lee, K. C., Lee, D. C., Armstrong, L., Cowell, I. G., & Austin, C. A. (2019) · Molecular Pharmacology · doi:10.1124/mol.119.117259 · Cited by 54
Febuxostat ameliorates doxorubicin-induced cardiotoxicity in rats
Krishnamurthy, B., Rani, N., Bharti, S., Golechha, M., Bhatia, J., Nag, T. C., Ray, R., Arava, S., & Arya, D. S. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.05.013 · Cited by 53
Beer, L. A., Kossenkov, A. V., Liu, Q., Prak, E. T. L., Domchek, S. M., Speicher, D. W., & Ky, B. (2016) · Circulation Research · doi:10.1161/circresaha.116.309004 · Cited by 52
Zhou, L., Li, R., Liu, C.-Y., Sun, T., Aung, L. H. H., Chen, C., Gao, J., Zhao, Y., & Wang, K. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.037 · Cited by 51
Cui, N., Wu, F., Lu, W., Bai, R., Ke, B., Liu, T., Li, L., Lan, F., & Cui, M. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14346 · Cited by 49
Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity
Lee, K. H., Cho, H., Lee, S., Woo, J. S., Cho, B. H., Kang, J. H., Jeong, Y., Cheng, X. W., & Kim, W. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.01.123 · Cited by 47
Endothelium-Derived Nitric Oxide as an Antiatherogenic Mechanism: Implications for Therapy
Sukhovershin, R. A., Yepuri, G., & Ghebremariam, Y. T. (2015) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-11-3-166 · Cited by 46
Aung, L. H. H., Li, R., Prabhakar, B. S., & Li, P. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13250 · Cited by 44
The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat
Ashtar, M., Tenshin, H., Teramachi, J., Bat‐Erdene, A., Hiasa, M., Oda, A., Tanimoto, K., Shimizu, S., Higa, Y., Harada, T., et al. (2020) · Cancers · doi:10.3390/cancers12040929 · Cited by 43
Tang, F., Zhou, X., Wang, L., Shan, L., Li, C., Zhou, H., Lee, S. M., & Hoi, M. P. M. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.12.021 · Cited by 42
Leung, W.-S., Kuo, W., Ju, D., Wang, T.-D., Chen, W. S., Ho, T., Lin, Y. M., Mahalakshmi, B., Lin, J., & Huang, C. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.07.018 · Cited by 42
Low shear stress induces vascular eNOS uncoupling via autophagy-mediated eNOS phosphorylation
Zhang, J., Qu, X., Chu, P., Xie, D., Zhu, L., Chao, Y., Li, L., Zhang, J., & Chen, S. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.02.005 · Cited by 40
Tedesco, L., Rossi, F., Ragni, M., Ruocco, C., Brunetti, D., Carruba, M. O., Torrente, Y., Valerio, A., & Nisoli, E. (2020) · Nutrients · doi:10.3390/nu12020282 · Cited by 39
Circular RNA Arhgap12 modulates doxorubicin-induced cardiotoxicity by sponging miR-135a-5p
Wang, X., Cheng, Z., Xu, J., Feng, M., Zhang, H., Zhang, L., & Qian, L. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118788 · Cited by 37
SIRT1 mediates the protective function of Nkx2.5 during stress in cardiomyocytes
Zheng, W., Lu, Y., Liang, S., Zhang, Q.-J., Xu, J., She, Z., Zhang, Z., Yang, R., Mao, B., Xu, Z., et al. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0364-y · Cited by 28
Todorova, V. K., Siegel, E. R., Kaufmann, Y., Kumarapeli, A. R., Owen, A., Wei, J. Y., Makhoul, I., & Klimberg, V. S. (2020) · Translational Oncology · doi:10.1016/j.tranon.2019.12.006 · Cited by 28
Pathologic Stimulus Determines Lineage Commitment of Cardiac C-kit+Cells
Chen, Z., Zhu, W., Bender, I. K., Gong, W., Kwak, I., Yellamilli, A., Hodges, T. J., Nemoto, N., Zhang, J. J., Garry, D. J., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.030137 · Cited by 27
Changing Hearts and Minds: Improving Outcomes in Cancer Treatment-Related Cardiotoxicity
Shelburne, N., Simonds, N. I., Adhikari, B. B., Alley, M. C., Desvigne-Nickens, P. M., Dimond, E. P., Filipski, K. K., Gallicchio, L. M., & Minasian, L. M. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0751-0 · Cited by 27
Doroshow, J. H., Esworthy, R. S., & Chu, F. (2019) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2019.100709 · Cited by 26
Tayeh, Z., & Ofir, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082219 · Cited by 25
Zerikiotis, S., Angelidis, C. E., Dhima, I., Naka, K. Κ., Kasioumi, P., Kalfakakou, V., Peschos, D., & Vezyraki, P. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3469-7 · Cited by 25
Follistatin-Like 1 Protects against Doxorubicin-Induced Cardiomyopathy through Upregulation of Nrf2
Zhao, Y., Sun, J., Zhang, W., Peng, M., Chen, J., Zheng, L., Zhang, X., Yang, H., & Liu, Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/3598715 · Cited by 24
Self-citationDudka, J., Burdan, F., Korga-Plewko, A., Iwan, M., Madej, B., Cendrowska‐Pinkosz, M., Korobowicz‐Markiewicz, A., Jodłowska‐Jędrych, B., & Matysiak, W. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/139327 · Cited by 17
Zheng, K., Jiang, Y., Liao, C., Hu, X., Li, Y., Zeng, Y., Zhang, J., Wu, X., Wu, H., Liu, L., et al. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b02296 · Cited by 12
Cited by
Wu, L., Wang, L., Du, Y., Zhang, Y., & Ren, J. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.10.003 · Cited by 257
Metadata
- Authors
- Kong, C.-Y., Guo, Z., Song, P., Zhang, X., Yuan, Y.-P., Teng, T., Yan, L., & Tang, Q.-Z.
- Venue
- International Journal of Biological Sciences
- Publisher
- Ivyspring International Publisher
- Published
- 2022
- Volume
- 18
- Issue
- 2
- Pages
- 760-770
- ISSN
- 1449-2288 (ISSN-L)
- OpenAlex
- W4200250025
- Cited by
- 412
- References
- 104
- FWCI
- 28.26
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.